XML 31 R24.htm IDEA: XBRL DOCUMENT
v3.25.1

Net Income Per Share | 6 Months Ended
--- | ---
Mar. 31, 2025
Earnings Per Share [Abstract] |
Net Income Per Share | 15. NET INCOME PER SHARE: The following table presents shares used in the calculation of basic and diluted net income per share:
| Three Months Ended |  |  | Six Months Ended |  |
| March 31, |  |  | March 31, |  |
| 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |  |
Weighted average common shares outstanding used in calculating basic net income per share |  | 22,616,518 |  |  |  | 22,299,599 |  |  |  | 22,616,069 |  |  |  | 22,247,587 |  |
Effect of dilutive options and non-vested restricted stock awards |  | 707,829 |  |  |  | 699,630 |  |  |  | 738,787 |  |  |  | 656,253 |  |
Weighted average common and common equivalent shares used in calculating diluted net income per share |  | 23,324,347 |  |  |  | 22,999,229 |  |  |  | 23,354,856 |  |  |  | 22,903,840 |  |
For the three months ended March 31, 2025 and 2024, there were 151,709 and 5,000 weighted average shares of options outstanding and non-vested restricted stock outstanding, respectively, that were not included in the computation of diluted net income per share because the options’ exercise prices or non-vested restricted stock prices were greater than the average market price of our common stock, and therefore, their effect would be anti-dilutive. For the six months ended March 31, 2025 and 2024, there were 15,819 and 5,000 weighted average shares of options outstanding and non-vested restricted stock outstanding, respectively, that were not included in the computation of diluted net income per share because the options’ exercise prices or non-vested restricted stock prices were greater than the average market price of our common stock, and therefore, their effect would be anti-dilutive.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration